H. Kröning

4.5k citations
26 papers · 1.5k indexed · 1 hit paper · h-index 13

Impact in

  • Oncology top 2%
    • Colorectal Cancer Treatments and Studies
    • Cancer Treatment and Pharmacology
    • Venous Thromboembolism Diagnosis and Management

Papers in

    • Colorectal Cancer Treatments and Studies 14
    • Cancer Treatment and Pharmacology 7
    • Peptidase Inhibition and Analysis 3
    • Genetic factors in colorectal cancer 5

H. Kröning

24 papers receiving 1.4k citations

Hit Papers

EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer 2008 · 726 citations
7262008202620142020200400600

Peers

H. Kröning
Comparison fields: 5 of 75
  • Oncology 1.0k
  • Internal Medicine 134
  • Hepatology 231
  • Pulmonary and Respiratory Medicine 592
  • Emergency Medical Services 120
Replace Lothar Müller with:
Lothar Müller Germany
Alec Goldenberg United States
M. Clerici Italy
Thomas J. Semrad United States
Laura Visa Spain
Wen-Qi Jiang China
Giuseppe Fornarini Italy
Heung Moon Chang South Korea
Barbara Bournet France
Mustapha Tehfé Canada
H. Kröning relative to Lothar Müller Germany Lothar Müller's profile →
Citations per field
00.5×2.7×
Lothar Müller · 1×
Citations per year

Countries citing papers authored by H. Kröning

Since Specialization
Citations

This map shows the geographic impact of H. Kröning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Kröning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Kröning more than expected).

Fields of papers citing papers by H. Kröning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Kröning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Kröning. The network helps show where H. Kröning may publish in the future.

Co-authorship network

The 25 scholars most cited alongside H. Kröning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with H. Kröning Line = papers co-authored together H. Kröning links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20210
2 20161
3 20153
4 20141
5 201429
6 20142
7 201248
8 20123
9 200759
10 2005159
11 200512
12 200458
13 20033
14 200221
15 2001136
16 19991
17 199719
18
Membrane-bound proteindisulfide isomerase (PDI) is involved in regulation of surface expression of thiols and drug sensitivity of B-CLL cells.
199769
19 199637
20 199433

About H. Kröning

H. Kröning is a scholar working on Oncology, Pathology and Forensic Medicine, Internal Medicine, Cancer Research and Physiology, having authored 26 papers that have together received 1.5k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (14 papers), Cancer Treatment and Pharmacology (7 papers), Genetic factors in colorectal cancer (5 papers), Colorectal and Anal Carcinomas (4 papers), Cancer Genomics and Diagnostics (4 papers), Cancer therapeutics and mechanisms (3 papers), Peptidase Inhibition and Analysis (3 papers) and Gastric Cancer Management and Outcomes (3 papers). The work is most often cited by research in Oncology (1.0k citations), Internal Medicine (134 citations), Hepatology (231 citations), Pulmonary and Respiratory Medicine (592 citations) and Emergency Medical Services (120 citations). H. Kröning has collaborated with scholars based in Germany, Switzerland and Austria. Frequent co-authors include Werner Scheithauer, Angela Zubel, Heinz‐Josef Lenz, Howard A. Burris, Joan Maurel, Gary Middleton, Justin Kopit, M. E. Vega-Villegas, E.U. Steinhauer and Jana Prausová. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, European Journal of Cancer, Scandinavian Journal of Immunology and Acta Haematologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026